THE PENNANT GROUP, INC. (PNTG) Current Ratio
- Current ratio · latest quarter: Value 1.20×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.20× | Current assets / current liabilities. $183.59M ÷ $152.41M ≈ 1.20× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 183.59M USD | Assets, Current |
| Current obligations | 152.41M USD | Liabilities, Current |
| Cash and equivalents | (m) | |
| Short-term securities | (m) | |
| Customer receivables | 133.18M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 26.24M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 5.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $183.59M | $152.41M | (m) | (m) | $133.18M | (m) | $26.24M | $5.00M | 1.20× |
| 2026-03-31 | $152.82M | $128.57M | (m) | (m) | $122.82M | (m) | $22.80M | $5.00M | 1.19× |
| 2025-12-31 | $167.41M | $147.26M | (m) | (m) | $123.11M | (m) | $25.17M | $5.00M | 1.14× |
| 2025-09-30 | $113.97M | $109.35M | (m) | (m) | $96.08M | (m) | $21.63M | (m) | 1.04× |
| 2025-06-30 | $127.37M | $104.94M | (m) | (m) | $95.72M | (m) | $19.21M | (m) | 1.21× |
| 2025-03-31 | $123.89M | $87.97M | (m) | (m) | $94.99M | (m) | $18.80M | (m) | 1.41× |
| 2024-12-31 | $122.86M | $101.70M | (m) | (m) | $81.30M | (m) | $18.74M | $0.00 | 1.21× |
| 2024-09-30 | $101.80M | $90.59M | (m) | (m) | $84.03M | (m) | $15.89M | (m) | 1.12× |
| 2024-06-30 | $94.11M | $83.69M | (m) | (m) | $76.09M | (m) | $15.39M | (m) | 1.12× |
| 2024-03-31 | $87.06M | $75.23M | (m) | (m) | $71.35M | (m) | $13.06M | (m) | 1.16× |
| 2023-12-31 | $80.08M | $71.55M | (m) | (m) | $61.12M | (m) | $10.84M | (m) | 1.12× |
| 2023-09-30 | $72.20M | $68.76M | (m) | (m) | $59.35M | (m) | $12.18M | (m) | 1.05× |
| 2023-06-30 | $71.64M | $68.48M | (m) | (m) | $57.25M | (m) | $12.04M | (m) | 1.05× |
| 2023-03-31 | $66.75M | $65.63M | (m) | (m) | $50.66M | (m) | $12.16M | (m) | 1.02× |
| 2022-12-31 | $73.82M | $70.25M | (m) | (m) | $53.42M | (m) | $13.65M | (m) | 1.05× |
| 2022-09-30 | $66.88M | $72.76M | (m) | (m) | $51.60M | (m) | $12.75M | (m) | 0.92× |
| 2022-06-30 | $74.64M | $74.87M | (m) | (m) | $53.15M | (m) | $12.72M | (m) | 1.00× |
| 2022-03-31 | $81.51M | $68.61M | (m) | (m) | $56.92M | (m) | $10.91M | (m) | 1.19× |
| 2021-12-31 | $75.84M | $71.64M | (m) | (m) | $53.94M | (m) | $10.55M | (m) | 1.06× |
| 2021-09-30 | $74.96M | $76.53M | (m) | (m) | $53.40M | (m) | $9.76M | (m) | 0.98× |
| 2021-06-30 | $73.48M | $82.82M | (m) | (m) | $52.14M | (m) | $8.32M | (m) | 0.89× |
| 2021-03-31 | $71.70M | $88.44M | (m) | (m) | $50.76M | (m) | $8.58M | (m) | 0.81× |
| 2020-12-31 | $59.60M | $89.02M | (m) | (m) | $47.22M | (m) | $9.76M | (m) | 0.67× |
| 2020-09-30 | $53.45M | $83.27M | (m) | (m) | $35.87M | (m) | $7.77M | (m) | 0.64× |
| 2020-06-30 | $52.43M | $80.46M | (m) | (m) | $33.86M | (m) | $7.22M | (m) | 0.65× |
| 2020-03-31 | $46.01M | $48.98M | (m) | (m) | $35.55M | (m) | $8.31M | (m) | 0.94× |
| 2019-12-31 | $38.68M | $51.19M | (m) | (m) | $32.18M | (m) | $8.65M | (m) | 0.76× |
| 2019-09-30 | $33.90M | $50.59M | (m) | (m) | $30.25M | (m) | $4.74M | (m) | 0.67× |
| 2018-12-31 | $29.12M | $29.55M | (m) | (m) | $24.47M | (m) | $4.39M | (m) | 0.99× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |